Page last updated: 2024-09-04

tipifarnib and lenvatinib

tipifarnib has been researched along with lenvatinib in 2 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(lenvatinib)
Trials
(lenvatinib)
Recent Studies (post-2010) (lenvatinib)
3099294975112946

Protein Interaction Comparison

ProteinTaxonomytipifarnib (IC50)lenvatinib (IC50)
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.0162
Platelet-derived growth factor receptor betaHomo sapiens (human)0.039
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.051
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.022
Kinesin-1 heavy chainHomo sapiens (human)0.01
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0052
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0035
Nuclear receptor coactivator 4Homo sapiens (human)0.01
Coiled-coil domain-containing protein 6Homo sapiens (human)0.01

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Atkins, J; Busaidy, N; Fu, S; Hong, D; Kurzrock, R; Naing, A; Sherman, S; Wheler, J1

Trials

1 trial(s) available for tipifarnib and lenvatinib

ArticleYear
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Biomarkers, Tumor; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-ret; Pyridines; Pyrroles; Quinolines; Quinolones; Retrospective Studies; Sorafenib; Sunitinib; Thyroid Neoplasms; Treatment Outcome; Valproic Acid

2013

Other Studies

1 other study(ies) available for tipifarnib and lenvatinib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013